Search research articles
Contact Us
Filters
Showing results (11-20 of 84) with videos related to
Page
of 9
Sort By:
Frontiers in Pharmacology
|
July 14, 2015
Central mechanisms mediating the hypophagic effects of oleoylethanolamide and N-acylphosphatidylethanolamines: different lipid signals?
Adele Romano, Bianca Tempesta, Gustavo Provensi, et al.
Journal of Alzheimer'S Disease : JAD
|
August 23, 2014
The role of endocannabinoid signaling in the molecular mechanisms of neurodegeneration in Alzheimer's disease
Gaurav Bedse, Adele Romano, Angelo M Lavecchia, et al.
Frontiers in Neuroscience
|
January 22, 2016
From Autism to Eating Disorders and More: The Role of Oxytocin in Neuropsychiatric Disorders
Adele Romano, Bianca Tempesta, Maria Vittoria Micioni Di Bonaventura, et al.
Biomed Research International
|
May 7, 2014
Oleoylethanolamide: a novel potential pharmacological alternative to cannabinoid antagonists for the control of appetite
Adele Romano, Roberto Coccurello, Giacomo Giacovazzo, et al.
Pharmacological Research
|
June 3, 2026
Bridging appetite and emotional dynamics: the oxytocinergic system as a therapeutic axis in feeding and eating disorders
Barbara Eramo, Christian Sepe, Marzia Friuli, et al.
Psychopharmacology
|
March 21, 2014
Differences in the structure of drinking, cart expression and dopamine turnover between polydipsic and non polydipsic rats in the quinpirole model of psychotic polydipsia
Chiara Schepisi, Silvia Cianci, Gaurav Bedse, et al.
Journal of Neurochemistry
|
September 22, 2016
Eating disorders: from bench to bedside and back
Silvana Gaetani, Adele Romano, Gustavo Provensi, et al.
Frontiers in Neuroscience
|
February 18, 2017
Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target
Tommaso Cassano, Silvio Calcagnini, Lorenzo Pace, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 8, 2004
Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation
Darren Fegley, Silvana Gaetani, Andrea Duranti, et al.
International Review of Neurobiology
|
July 18, 2009
The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs
Silvana Gaetani, Pasqua Dipasquale, Adele Romano, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 84) with videos related to
Sort By:
Page
of 9
Frontiers in Pharmacology
|
July 14, 2015
Central mechanisms mediating the hypophagic effects of oleoylethanolamide and N-acylphosphatidylethanolamines: different lipid signals?
Adele Romano, Bianca Tempesta, Gustavo Provensi, et al.
Journal of Alzheimer'S Disease : JAD
|
August 23, 2014
The role of endocannabinoid signaling in the molecular mechanisms of neurodegeneration in Alzheimer's disease
Gaurav Bedse, Adele Romano, Angelo M Lavecchia, et al.
Frontiers in Neuroscience
|
January 22, 2016
From Autism to Eating Disorders and More: The Role of Oxytocin in Neuropsychiatric Disorders
Adele Romano, Bianca Tempesta, Maria Vittoria Micioni Di Bonaventura, et al.
Biomed Research International
|
May 7, 2014
Oleoylethanolamide: a novel potential pharmacological alternative to cannabinoid antagonists for the control of appetite
Adele Romano, Roberto Coccurello, Giacomo Giacovazzo, et al.
Pharmacological Research
|
June 3, 2026
Bridging appetite and emotional dynamics: the oxytocinergic system as a therapeutic axis in feeding and eating disorders
Barbara Eramo, Christian Sepe, Marzia Friuli, et al.
Psychopharmacology
|
March 21, 2014
Differences in the structure of drinking, cart expression and dopamine turnover between polydipsic and non polydipsic rats in the quinpirole model of psychotic polydipsia
Chiara Schepisi, Silvia Cianci, Gaurav Bedse, et al.
Journal of Neurochemistry
|
September 22, 2016
Eating disorders: from bench to bedside and back
Silvana Gaetani, Adele Romano, Gustavo Provensi, et al.
Frontiers in Neuroscience
|
February 18, 2017
Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target
Tommaso Cassano, Silvio Calcagnini, Lorenzo Pace, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 8, 2004
Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation
Darren Fegley, Silvana Gaetani, Andrea Duranti, et al.
International Review of Neurobiology
|
July 18, 2009
The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs
Silvana Gaetani, Pasqua Dipasquale, Adele Romano, et al.
Page
of 9